Back to Journals » Drug Design, Development and Therapy » Volume 9

Current and emerging treatment options for ANCA-associated vasculitis: potential role of belimumab and other BAFF/APRIL targeting agents

Total article views   HTML views PDF downloads Totals
20,576 Dovepress* 15,814+ 2,194 18,008
PubMed Central* 4,762 1,494 6,256
Totals 20,576 3,688 24,264
*Since 7 January 2015
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
6 0 0 0 2 4

View citations on PubMed Central and Google Scholar